These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. Cagnacci A; Paoletti AM; Renzi A; Orrù M; Pilloni M; Melis GB; Volpe A J Clin Endocrinol Metab; 2003 Aug; 88(8):3621-5. PubMed ID: 12915645 [TBL] [Abstract][Full Text] [Related]
31. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas. Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748 [TBL] [Abstract][Full Text] [Related]
32. Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone. Ozdemir S; Ozdemir M; Toy H J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):358-9. PubMed ID: 18540980 [No Abstract] [Full Text] [Related]
33. Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis. Razzi S; Luisi S; Ferretti C; Calonaci F; Gabbanini M; Mazzini M; Petraglia F Eur J Obstet Gynecol Reprod Biol; 2007 Dec; 135(2):188-90. PubMed ID: 16963174 [TBL] [Abstract][Full Text] [Related]
34. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome. Falsetti L; Dordoni D; Gastaldi C; Gastaldi A Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960 [TBL] [Abstract][Full Text] [Related]
35. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea. Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222 [TBL] [Abstract][Full Text] [Related]
36. Estrogen-progestagen therapy in the management of the polycystic ovary syndrome. Marshall JC J Endocrinol Invest; 1998 Oct; 21(9):618-22. PubMed ID: 9856416 [No Abstract] [Full Text] [Related]